Investing.com - Gossamer Bio (NASDAQ: GOSS) reported third quarter EPS of $-0.140, better than the analyst estimate of $-0.150. Revenue for the quarter came in at $9.48M versus the consensus estimate of $8.53M.
Gossamer Bio's stock price closed at $0.89. It is up 12.110% in the last 3 months and up 61.270% in the last 12 months.
Gossamer Bio saw 7 positive EPS revisions and 1 negative EPS revisions in the last 90 days. See Gossamer Bio's stock price’s past reactions to earnings here.
According to InvestingPro, Gossamer Bio's Financial Health score is "good performance".
Check out Gossamer Bio's recent earnings performance, and Gossamer Bio's financials here.
Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com's earnings calendar